Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 4. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 5. Rapid correction of low vitamin D status in nursing home residents
Top Ten Searches
etanercept hypertension chf antiphospholipid fibrosis mrsa scid renal cell rickets counterpulsationYour Article Summary
Levocetirizine for the treatment of allergic rhinitis and chronic idiopathic urticaria in adults and children
Clinical Therapeutics, 10/16/09
Singh–Franco D et al. – In the studies reviewed, LCZ 5 mg/d was effective in reducing symptoms of PAR, SAR, and CIU and improving QoL, with an acceptable tolerabili–ty profile. There is a need for studies of longer durations, head–to–head comparisons against other anti–histamines, drug–interaction studies, safety studies in infants, and cost–effectiveness analyses.
Related Articles
Allergy drug tackles nasal congestion
Reuters, 11/13/09
Relevance Score: 81%
Mechanisms and clinical implications of glucocorticosteroids in the treatment of allergic rhinitis
Clinical and Experimental Immunology, 10/05/09
Relevance Score: 81%
Clinical Studies of Combination Montelukast and Loratadine in Patients with Seasonal Allergic Rhinitis
Journal of Asthma, 11/11/09
Relevance Score: 79%
Effect of natural seasonal pollen exposure and repeated nasal allergen provocations on elevation of exhaled nitric oxide
Allergy, 10/20/09
Relevance Score: 78%
Efficacy and safety of azelastine 0.15% nasal spray administered once daily in subjects with seasonal allergic rhinitis
Allergy and Asthma Proceedings, 10/13/09
Relevance Score: 78%
Today in Allergy/Immunology...keeping you current
Receive free subspecialty "5-minute updates" via email
Anti-TNF-[alpha] therapy with infliximab in spondyloarthritides
Expert Review of Clinical Immunology, 12/17/09
Differential requirements for IL-4/STAT6 signalling in CD4 T-cell fate determination and Th2-immune effector responses
Immunology & Cell Biology, 12/17/09
Allergen IgE-isotype-specific suppression by maternally derived monoclonal anti-IgG-idiotype
Allergy, 12/17/09
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Resorption and elimination kinetics of benzoic acid during chemical necrectomy in deep burns
Scandinavian Journal of Clinical and Laboratory Investigation, 12/19/09
Dienogest: a new therapeutic agent for the treatment of endometriosis *TEST*
Women's Health, 12/17/09
A prospective phase II study of cetuximab in combination with XELOX (capecitabine and oxaliplatin) in patients with metastatic and/or recurrent advanced gastric cancer
Investigational New Drugs, 12/17/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


